Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04629521 · ClinicalTrials.gov registry record · NA
Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT04629521 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 54 participants.
The verdict
NCT04629521, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to assess long-term (10 years post-CyPass implantation) status of the corneal endothelium in subjects who were implanted with the CyPass Micro-Stent in the COMPASS trial.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE CyPass Micro-Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2023-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04629521
The ClinicalTrials.gov registry entry for NCT04629521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract Surgery is the first listed.
NCT04629521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04629521 about?
NCT04629521 is a clinical study titled "Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent". The purpose of this study is to assess long-term (10 years post-CyPass implantation) status of the corneal endothelium in subjects who were implanted with the CyPass Micro-Stent in the COMPASS trial.
What is the current status of trial NCT04629521?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2020-12-21. Estimated completion is 2023-04-05.
What interventions are being tested in trial NCT04629521?
The interventions under investigation include: Cataract Surgery (PROCEDURE), CyPass Micro-Stent (DEVICE).
Who is sponsoring clinical trial NCT04629521?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.